Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Biol Psychiatry
1 Br J Psychiatry
1 Mol Psychiatry
1 Neurosci Lett
1 PLoS One
2 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Biol Psychiatry

  1. ENDRES D, von Zedtwitz K, Matteit I, Bunger I, et al
    Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
    Biol Psychiatry. 2022 Feb 19. pii: S0006-3223(22)00097.
    PubMed         Abstract available

    Br J Psychiatry

    Identification of specific genes involved in schizophrenia aetiology - what difference does it make? - CORRIGENDUM.
    Br J Psychiatry. 2022 May 23:1. doi: 10.1192/bjp.2022.

    Mol Psychiatry

  3. PERZEL MANDELL KA, Eagles NJ, Deep-Soboslay A, Tao R, et al
    Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus.
    Mol Psychiatry. 2022;27:2061-2067.
    PubMed         Abstract available

    Neurosci Lett

  4. REN J, Chen Y, Fang X, Wang D, et al
    Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
    Neurosci Lett. 2022 May 23:136695. doi: 10.1016/j.neulet.2022.136695.
    PubMed         Abstract available

    PLoS One

  5. ALGUMAEI AH, Algunaid RF, Rushdi MA, Yassine IA, et al
    Feature and decision-level fusion for schizophrenia detection based on resting-state fMRI data.
    PLoS One. 2022;17:e0265300.
    PubMed         Abstract available

    Schizophr Res

  6. WILLIAMS TF, Powers AR, Ellman LM, Corlett PR, et al
    Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis.
    Schizophr Res. 2022;244:58-65.
    PubMed         Abstract available

  7. SCHIFFMAN J, Horton LE, Landa Y, Woods SW, et al
    Considerations for providing feedback to patients and families regarding clinical high-risk for psychosis status.
    Schizophr Res. 2022;244:55-57.

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.